Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study

Author:

Kos Igor Age12,Hajar Faissal Nemer1,Sarot Pereira da Cunha Gustavo1,Corte Claudia3,Furlan Luisa Augusto3,Santa Maria André3ORCID,Valverde Douglas4ORCID,Emoingt Furtado Bárbara3,Morita Fernandes-Silva Miguel15,Feijó Azevedo Valderilio15ORCID

Affiliation:

1. Edumed Educação em Saúde, 2495 Bispo Dom José Street, Curitiba 80440-080, Brazil

2. Department of Internal Medicine I, Hematology, Oncology and Rheumatology, Saarland University Medical Center, Kirrbergstr. 100, 66424 Homburg, Germany

3. AstraZeneca Brazil, Raposo Tavares Road, KM 26.9, Cotia 06709-000, Brazil

4. Techtrials, Dr. Ovídio Pires de Campos Street, São Paulo 05403-010, Brazil

5. Department of Internal Medicine, Federal University of Paraná, Rua General Carneiro, 181, 10° Andar, Alto da Glória, Curitiba 80060-900, Brazil

Abstract

Objective: Brazil was strongly affected by the COVID-19 pandemic. Its continental dimension and socio-demographic characteristics pose challenges to distribution and accessibility, making vaccination programs challenging. The objectives of the study were to describe the clinical and demographic characteristics of the general population vaccinated against COVID-19 by October 2021 and analyze the strategies implemented during the vaccination program. Study design and setting: A retrospective nationwide study that analyzed data from the OpenDataSUS platform of the Informatics Department of the Brazilian Ministry of Health (DataSUS), which contains information from all individuals in Brazil who have received at least one dose of any vaccine against COVID-19 approved by the National Health Agency (ANVISA) from 17 January to 3 October 2021. Results: Until 3 October, a total of 146,254,578 persons (68.6 per 100 inhabitants) received at least one dose of a vaccine in Brazil. The north and northeast regions had the lowest vaccination rates compared with the remaining regions (North: 56.8, Northeast: 62.0, South: 74.4, and Southeast: 73.2 per 100 inhabitants). Elderly individuals had the highest vaccination rates, particularly those above 70 years old. Heterologous dosing regimens were administered to 1,063,079 individuals (0.7% of those receiving the first dose). Conclusions: The COVID-19 vaccination program reached more than two-thirds of the population in Brazil by 9 months after its start, but the vaccination coverage was heterogeneous, reflecting the country’s geographic and socio-demographic characteristics. Establishing priority groups for vaccination was a main characteristic of the vaccination strategy. In addition, technology transfer agreements have played an important role in increasing vaccine accessibility.

Funder

AstraZeneca Brasil

Publisher

MDPI AG

Reference39 articles.

1. (2021, October 19). WHO Coronavirus (COVID-19) Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https://covid19.who.int/.

2. (2021, October 19). Coronavírus Brasil, Available online: https://covid.saude.gov.br/.

3. WHO Solidarity Trial Consortium (2021). Repurposed Antiviral Drugs for COVID-19—Interim WHO Solidarity Trial Results. N. Engl. J. Med., 384, 497–511.

4. Prevention of host-to-host transmission by SARS-CoV-2 vaccines;Mostaghimi;Lancet Infect. Dis.,2021

5. Effect of Vaccination on Transmission of SARS-CoV-2;Shah;N. Engl. J. Med.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3